News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Fiona BARRY
- Last updated on
The Weinberg Group, a regulatory consulting firm for pharmaceutical clients, has appointed Phil Smith as VP, Europe. He will be based in Bristol, UK.
Smith has worked in pharmaceuticals for 20 years at PZJ Executive, Vitrology, United Drug Packaging, Thermo Fisher Scientific, and STERIS, with experience in market development and product campaigns in Europe, the Middle East, Africa and North America.
The Group’s CEO, Matthew Weinberg, told Outsourcing-Pharma.com customers’ attitudes to drug approval were changing:
“Aside from the obvious drive for cheaper and faster approaches to coping with Federal regulation, sponsors are working to simplify the approval process. The Weinberg Group is seeing a trend of clients looking to determine how to get on the market with the first indication, and then use that as the spring board for the next step,” he said.
“Instead of possibly seeking the most lucrative indication, more firms are now looking for that first market approval, regardless of the revenue stream involved.”